Insiders who reported open-market trades in the last 12 months at the companies Meredith Cook files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Nikhil Lalwani - $5.05M in ANIP purchases and sales in the last 12 months
Patrick D. Walsh - $2.32M in ANIP purchases and sales in the last 12 months
Stephen P. Carey - $1.99M in ANIP purchases and sales in the last 12 months
Christopher Mutz - $1.64M in ANIP purchases and sales in the last 12 months
Chad Gassert - $1.31M in ANIP purchases and sales in the last 12 months
Krista Davis - $785K in ANIP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Meredith Cook is a corporate insider, tracked as SR. VP, GENERAL COUNSEL & SEC. of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha holds 25 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Meredith Cook submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Meredith Cook been buying or selling stock?
Recorded transactions: 0 open-market purchases and 21 open-market sales ($679K) across all tracked filings.
Meredith Cook is SR. VP, GENERAL COUNSEL & SEC. of ANI PHARMACEUTICALS INC (ANIP). 25 SEC Form 4 filings on record going back to 2024, most recently on 14 October 2026. Most recent open-market trade: sold $37K of ANIP on 14 October 2026. Lifetime open-market sales: $679K.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Meredith Cook.
InsiderAlpha's records for Meredith Cook go back to 2024: 25 primary Form 4 filings, an average of 8.3 per year. 17 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
